Answers are grounded in this paper and cite their sources.
The purpose of this study was to create a gliclazide bilayer tablet with bimodal drug release.The main objective of this study is to investigate the potential of xanthan gum as a bioadhesive, sustained-release layer.Here, xanthan gum is used with cross-carmellose, cross-povidone, and SSG.Swollen volume outside bioadhesion, dissolution kinetics, water absorption, and in vitro drug release were checked.A non-Ficki and diffusion-regulated release mechanism was used to study dissolution kinetics after the first burst, leading to the Higuchi model (R 2 = 0.9913).All 32 full factorial designs were considered in the current study.The optimal disintegration time for the direct compression technique utilizing cross-povidone resulted in the immediate release formulation (IR3).According to the disintegration testing results, the time was 13 seconds.In the formulation, the kind of polymers coupled with xanthan gum and the amount of polymer substituted with sodium cross-carmellose were considered independent variables.It was possible to adequately incorporate the mucilage into tablets while preserving high adhesiveness and sustained drug release by replacing only 20% of the natural mucilage, such as xanthan gum, with cross-carmellose sodium.
No takes yet. Share an insight, caveat, or question.
Pimpale et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: